Overview History Clinical Philosophy Leadership Advisory Boards Locations Stem for Life
Cell Therapeutics Development Amorcyte Athelos VSEL™ Technology Wound Technology Intellectual Property
Overview Enabling Development
Pharmaceuticals Stem Cell Banking
News Media Coverage Videos Images
Operating Divisions IR Events SEC Filings Email Alerts FAQs
Home Investor Relations IR Contact
Robin Smith, CEO Phone: (212) 584-4174 email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Investor Email Registration Form